Myocardial InfarctionNCT02734082
The Brain Heart Interaction in Acute Stroke
An observational study of Myocardial Infarction and Stroke, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.
Trial summary
Many studies have shown that acute cerebral dysfunction can impair cardiac function and autonomic control of blood pressure, heart rate and vascular tone, however, the size of the stroke is rarely reported. Involvement of the insular cortex seems to predispose to cardiac damage and autonomic dysfunction. Read more about this study
- Who is it for?
- Ages 16 years and older
- Conditions the study is for
- Myocardial Infarction, Stroke
- How many people
- 204 participants
- Where
- 1 siteSwitzerland
- Study dates
- Oct 2013to Mar 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients with acute ischemic stroke hospitalized at Inselpital Berne between 2004-2014.
Who may be able to join
- Age ≥16 years
- Hospitalized between 2004-2014
- Acute MRI imaging performed
- ECG on admission
- Cardiac lab parameters on admission (TnT, CK, CK-MB)
Who cannot join
- Age <16 years
- No acute MRI image
- No lab parameters
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Dep. of Neurology, Bern University Hospital, Bern
Bern, Canton of Bern, 3010
About this study
Many studies have shown that acute cerebral dysfunction can impair cardiac function and autonomic control of blood pressure, heart rate and vascular tone, however, the size of the stroke is rarely reported. Involvement of the insular cortex seems to predispose to cardiac damage and autonomic dysfunction. However, it is not clear whether cardiac dysfunction is merely a marker of large strokes or location of the stroke is critical.
Read the detailed description
Background
On one hand structural cardiac anomalies and arrhythmias such as atrial fibrillation can give rise to thrombi that are dislodged as emboli to the brain and cause stroke. On the other hand acute emotional stress or cerebral events can cause acute cardiac dysfunction with left ventricular failure in the absence of cardiac causes. The extreme variant of stress cardiomyopathy is known as Takotsubo cardiomyopathy. Patients are presenting with chest pain, electrocardiographic changes similar to acute myocardial infarction with ST-segment elevation, T-wave inversion, or QT prolongation, and elevated cardiac biomarkers such as CK and troponin. When coronary angiography is performed coronary arteries are normal, but the left ventricle shows mostly apical and midventricular dyskinesia and apical ballooning or rarely basal akinesia and apical hyperkinesia. The exact pathogenesis is unknown. Presumably high catecholamine levels resulting from the extreme emotional stress or acute cerebral events cause severe peripheral vasospasms resulting in myocardial dysfunction.
It has been known for many decades that myocardial damage such as small patchy necroses and subendocardial hemorrhages and cardiac arrhythmias can occur after subarachnoid or intracerebral haemorrhage. Greenhout and Reichenbach and Weidler observed abnormally increased autonomic activity or an imbalance between parasympathetic and sympathetic input to the heart. Systematic analyses of heart and brain interactions were first performed by JW Norris and coworkers in Toronto. They examined cardiac enzymes in 230 acute stroke patients and found raised CK-MB in 25 (11%). They also found that catecholamine concentrations in stroke patients were higher than in controls, that patients with higher CK levels had higher norepinephrine levels, more often arrhythmias and such elevated CK and norepinephrine levels were more common in hemispheric compared to brain stem strokes. DiAngelantonio et al assessed cardiac troponin I levels on admission of 330 stroke patients. When troponin I levels were elevated the odds for in-hospital death or non-fatal cardiac events were increased. These results were corroborated in a systematic review of 15 similar studies. According to this review troponin was elevated in 18.1% of 2901 stroke patients. Patients with elevated troponin levels had an odds ratio of 3.0 (95% CI 1.5-6.2) for showing electrocardiographic changes and an odds ratio for death of 2.9 (95% CI 1.7-4.8). Hakan Ay and coworkers addressed the question whether stroke in specific brain areas are more prone to cardiac damage. In a case control study they analysed diffusion weighted MR images of patients with elevated troponin T levels (cTnT) and patients with normal levels to identify voxels with diffusion restriction that are associated with troponin elevation. Brain regions that were a priori associated with cTnT elevation included the right posterior, superior, and medial insula and the right inferior parietal lobule. Among patients with right middle cerebral artery infarction, the insular cluster was involved in 88% of patients with and 33% without cTnT elevation (odds ratio: 15.00; 95% CI: 2.65 to 84.79). Their findings indicate that the right insula is associated with elevated serum cardiac troponin T level indicative of myocardial injury. In an additional MR study using diffusion and perfusion imaging the same group of researchers found that infarctions encompassing the insula is associated with increased conversion of ischemic but potentially viable penumbral tissues into infarction. Unlike Ay et al Laowattana and coworkers found left insular stroke associated with an increased risk of adverse cardiac outcome and decreased cardiac wall motion compared to stroke in other locations and TIA. According to their findings left insular lesions show decreased parasympathetic tone and right insular lesions increased sympathetic drive. This results in abnormal fluctuations in blood pressure, abnormal circadian blood pressure patterns, higher norepinephrine levels and elevated blood pressure in acute stroke. Furthermore, baroreflex sensitivity has been found to be reduced after stroke, i.e. autonomic adjustment of heart rate and vascular tone to sudden blood pressure changes was compromised. Sykora et al demonstrated that baroreflex impairment in acute stroke is not associated with carotid atherosclerosis but with insular involvement. In their study both insulae seemed to participate in processing the baroreceptor information with the left insula being more dominant. Other authors found that there might be a hemispheric dominance of autonomic control and that impairment of cardiovascular autonomic control increases with higher NIHSS scores. The reason for the neuroanatomic correlation of insular strokes and myocardial injury and that middle cerebral artery stroke involving the insula are more prone to growth as found by Ay et al is not known. A hypothesis focuses on the tight connections of the insular cortex to the limbic system. Phylogenetically the limbic system belongs to the oldest parts of the brain. It encompasses a group of gyri and nuclei and interconnections in the center of the brain such as amygdala, hippocampus, gyrus cinguli, fornix, anterioventral thalamic nuclei, and hypothalamus. The main functions of the limbic system is controlling the endocrine and autonomic nervous system, emotional life and behavior, olfaction, pleasure, and short and long term memory and learning. Dysautonomia after stroke is independent whether stroke is ischemic or hemorrhagic. Similarly, excitation of the cortex in epilepsy can result in cardiac dysfunction. Epilepsy can cause ictal tachycardia and bradycardia and ECG changes, even if brain imaging does not show any structural abnormality. In addition, more than a third of epilepsy patients show ictal bradycardia that would merit insertion of a permanent pacemaker. Sudden unexpected death is increased five fold in epilepsy, and especially patients with treatment refractory generalised tonic clonic seizures are at risk. One of the main reasons might be brain heart interactions with asystole. To summarize, many studies have shown that acute cerebral dysfunction can impair cardiac function and autonomic control of blood pressure, heart rate and vascular tone, however, the size of the stroke is rarely reported. Involvement of the insular cortex seems to predispose to cardiac damage and autonomic dysfunction. However, it is not clear whether cardiac dysfunction is merely a marker of large strokes or location of the stroke is critical.
Objective
The aim of the proposed research is to answer the question whether both size of stroke and location are independent predictors of impairment of cardiac function in acute stroke.
Methods
This is a retrospective analysis of patients of the Bernese Stroke Data Base who all had a full MRI examination at admission. All acute stroke patients will be screened for Troponin elevations, abnormal electrocardiograms or both. Patients with primary cardiac causes or other reasons for troponin elevations or ECG changes will be handled separately. The study patients will be compared to at least 200 control stroke patients without troponin elevations and without ECG changes. Infarct location, vessel occlusions and volumes of diffusion restriction and perfusion deficit will be assessed on MR images. In a multivariable analysis, the investigators will find out whether Troponin elevations and ECG abnormalities are associated with infarct location or infarct size or both. In addition, the investigators will perform a voxel based analysis for correlation of infarct location and troponin elevations and ECG abnormalities.
- Conditions
- Myocardial Infarction, Stroke
- Keywords
- stroke, ischemia, Berne
- Medical subject headings
- Myocardial Infarction, Stroke, Ischemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Elevated Troponin and pathological EC | Patients with acute ischemic stroke with elevated Troponin | |
| No elevated Troponin or pathological EC | Patients with acute ischemic stroke without elevated Troponin | |
| Elevated Troponin, pathological ECG & coronary angiography | Patients with acute ischemic stroke with elevated Troponin T and pathological ECG and coronary angiography | |
| No elevated Troponin, pathological ECG & coronary angiography | Patients with acute ischemic stroke without elevated Troponin T and pathological ECG and coronary angiography |
What is being measured
The primary outcome is the main question the study is designed to answer.
Association of ischemic lesion size and impaired heart regulation at baseline
Association is to be determined via multivariate logistic regression. Baseline parameter at inclusion; functional outcome/mortality after 3 months.
Measured: At baseline
Association of ischemic lesion size and impaired heart regulation after 3 months
Association is to be determined via multivariate logistic regression. Baseline parameter at inclusion; functional outcome/mortality after 3 months.
Measured: After 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Apr 2016 (estimated)
- Study startOct 2013
- Primary completionMar 2015
- Study completionMar 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Myocardial InfarctionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 204 participants (actual)
Sponsor and investigators
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Heinrich P Mattle, Prof. MD, Principal investigator, Dep. of Neurology, Bern University Hospital, Bern
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02734082
- Sponsor's protocol ID
- 155/14
- Status last verified
- Apr 2016
- First submitted
- 24 Nov 2014
- Last updated
- 12 Apr 2016
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Edelman RR, Mattle HP, Atkinson DJ, Hill T, Finn JP, Mayman C, Ronthal M, Hoogewoud HM, Kleefield J. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology. 1990 Jul;176(1):211-20. doi: 10.1148/radiology.176.1.2353094.
PubMed 2353094Mattle HP, Wentz KU, Edelman RR, Wallner B, Finn JP, Barnes P, Atkinson DJ, Kleefield J, Hoogewoud HM. Cerebral venography with MR. Radiology. 1991 Feb;178(2):453-8. doi: 10.1148/radiology.178.2.1987608.
PubMed 1987608Galimanis A, Jung S, Mono ML, Fischer U, Findling O, Weck A, Meier N, De Marchis GM, Brekenfeld C, El-Koussy M, Mattle HP, Arnold M, Schroth G, Gralla J. Endovascular therapy of 623 patients with anterior circulation stroke. Stroke. 2012 Apr;43(4):1052-7. doi: 10.1161/STROKEAHA.111.639112. Epub 2012 Feb 23.
PubMed 22363057Heldner MR, Zubler C, Mattle HP, Schroth G, Weck A, Mono ML, Gralla J, Jung S, El-Koussy M, Ludi R, Yan X, Arnold M, Ozdoba C, Mordasini P, Fischer U. National Institutes of Health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke. Stroke. 2013 Apr;44(4):1153-7. doi: 10.1161/STROKEAHA.111.000604. Epub 2013 Mar 7.
PubMed 23471266Walpoth BH, Walpoth-Aslan BN, Mattle HP, Radanov BP, Schroth G, Schaeffler L, Fischer AP, von Segesser L, Althaus U. Outcome of survivors of accidental deep hypothermia and circulatory arrest treated with extracorporeal blood warming. N Engl J Med. 1997 Nov 20;337(21):1500-5. doi: 10.1056/NEJM199711203372103.
PubMed 9366581
Study at a glance
From the registry record, last updated by the sponsor on 12 Apr 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Brain Heart Interaction in Acute Stroke
- ClinicalTrials.gov ID
- NCT02734082
- Acronym / sponsor ID
- 155/14
- Conditions
- Myocardial Infarction, Stroke
- Keywords
- stroke, ischemia, Berne
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 204 participants (actual)
- Lead sponsor
- Insel Gruppe AG, University Hospital BernUniversity, hospital or other
- Study start
- Oct 2013
- Primary completion
- Mar 2015 (actual)
- Study completion
- Mar 2015 (actual)
- First posted
- 12 Apr 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Many studies have shown that acute cerebral dysfunction can impair cardiac function and autonomic control of blood pressure, heart rate and vascular tone, however, the size of the stroke is rarely reported. Involvement of the insular cortex seems to predispose to cardiac damage and autonomic dysfunction. However, it is not clear whether cardiac dysfunction is merely a marker of large strokes or location of the stroke is critical.
Detailed description
Background
On one hand structural cardiac anomalies and arrhythmias such as atrial fibrillation can give rise to thrombi that are dislodged as emboli to the brain and cause stroke. On the other hand acute emotional stress or cerebral events can cause acute cardiac dysfunction with left ventricular failure in the absence of cardiac causes. The extreme variant of stress cardiomyopathy is known as Takotsubo cardiomyopathy. Patients are presenting with chest pain, electrocardiographic changes similar to acute myocardial infarction with ST-segment elevation, T-wave inversion, or QT prolongation, and elevated cardiac biomarkers such as CK and troponin. When coronary angiography is performed coronary arteries are normal, but the left ventricle shows mostly apical and midventricular dyskinesia and apical ballooning or rarely basal akinesia and apical hyperkinesia. The exact pathogenesis is unknown. Presumably high catecholamine levels resulting from the extreme emotional stress or acute cerebral events cause severe peripheral vasospasms resulting in myocardial dysfunction.
It has been known for many decades that myocardial damage such as small patchy necroses and subendocardial hemorrhages and cardiac arrhythmias can occur after subarachnoid or intracerebral haemorrhage. Greenhout and Reichenbach and Weidler observed abnormally increased autonomic activity or an imbalance between parasympathetic and sympathetic input to the heart. Systematic analyses of heart and brain interactions were first performed by JW Norris and coworkers in Toronto. They examined cardiac enzymes in 230 acute stroke patients and found raised CK-MB in 25 (11%). They also found that catecholamine concentrations in stroke patients were higher than in controls, that patients with higher CK levels had higher norepinephrine levels, more often arrhythmias and such elevated CK and norepinephrine levels were more common in hemispheric compared to brain stem strokes. DiAngelantonio et al assessed cardiac troponin I levels on admission of 330 stroke patients. When troponin I levels were elevated the odds for in-hospital death or non-fatal cardiac events were increased. These results were corroborated in a systematic review of 15 similar studies. According to this review troponin was elevated in 18.1% of 2901 stroke patients. Patients with elevated troponin levels had an odds ratio of 3.0 (95% CI 1.5-6.2) for showing electrocardiographic changes and an odds ratio for death of 2.9 (95% CI 1.7-4.8). Hakan Ay and coworkers addressed the question whether stroke in specific brain areas are more prone to cardiac damage. In a case control study they analysed diffusion weighted MR images of patients with elevated troponin T levels (cTnT) and patients with normal levels to identify voxels with diffusion restriction that are associated with troponin elevation. Brain regions that were a priori associated with cTnT elevation included the right posterior, superior, and medial insula and the right inferior parietal lobule. Among patients with right middle cerebral artery infarction, the insular cluster was involved in 88% of patients with and 33% without cTnT elevation (odds ratio: 15.00; 95% CI: 2.65 to 84.79). Their findings indicate that the right insula is associated with elevated serum cardiac troponin T level indicative of myocardial injury. In an additional MR study using diffusion and perfusion imaging the same group of researchers found that infarctions encompassing the insula is associated with increased conversion of ischemic but potentially viable penumbral tissues into infarction. Unlike Ay et al Laowattana and coworkers found left insular stroke associated with an increased risk of adverse cardiac outcome and decreased cardiac wall motion compared to stroke in other locations and TIA. According to their findings left insular lesions show decreased parasympathetic tone and right insular lesions increased sympathetic drive. This results in abnormal fluctuations in blood pressure, abnormal circadian blood pressure patterns, higher norepinephrine levels and elevated blood pressure in acute stroke. Furthermore, baroreflex sensitivity has been found to be reduced after stroke, i.e. autonomic adjustment of heart rate and vascular tone to sudden blood pressure changes was compromised. Sykora et al demonstrated that baroreflex impairment in acute stroke is not associated with carotid atherosclerosis but with insular involvement. In their study both insulae seemed to participate in processing the baroreceptor information with the left insula being more dominant. Other authors found that there might be a hemispheric dominance of autonomic control and that impairment of cardiovascular autonomic control increases with higher NIHSS scores. The reason for the neuroanatomic correlation of insular strokes and myocardial injury and that middle cerebral artery stroke involving the insula are more prone to growth as found by Ay et al is not known. A hypothesis focuses on the tight connections of the insular cortex to the limbic system. Phylogenetically the limbic system belongs to the oldest parts of the brain. It encompasses a group of gyri and nuclei and interconnections in the center of the brain such as amygdala, hippocampus, gyrus cinguli, fornix, anterioventral thalamic nuclei, and hypothalamus. The main functions of the limbic system is controlling the endocrine and autonomic nervous system, emotional life and behavior, olfaction, pleasure, and short and long term memory and learning. Dysautonomia after stroke is independent whether stroke is ischemic or hemorrhagic. Similarly, excitation of the cortex in epilepsy can result in cardiac dysfunction. Epilepsy can cause ictal tachycardia and bradycardia and ECG changes, even if brain imaging does not show any structural abnormality. In addition, more than a third of epilepsy patients show ictal bradycardia that would merit insertion of a permanent pacemaker. Sudden unexpected death is increased five fold in epilepsy, and especially patients with treatment refractory generalised tonic clonic seizures are at risk. One of the main reasons might be brain heart interactions with asystole. To summarize, many studies have shown that acute cerebral dysfunction can impair cardiac function and autonomic control of blood pressure, heart rate and vascular tone, however, the size of the stroke is rarely reported. Involvement of the insular cortex seems to predispose to cardiac damage and autonomic dysfunction. However, it is not clear whether cardiac dysfunction is merely a marker of large strokes or location of the stroke is critical.
Objective
The aim of the proposed research is to answer the question whether both size of stroke and location are independent predictors of impairment of cardiac function in acute stroke.
Methods
This is a retrospective analysis of patients of the Bernese Stroke Data Base who all had a full MRI examination at admission. All acute stroke patients will be screened for Troponin elevations, abnormal electrocardiograms or both. Patients with primary cardiac causes or other reasons for troponin elevations or ECG changes will be handled separately. The study patients will be compared to at least 200 control stroke patients without troponin elevations and without ECG changes. Infarct location, vessel occlusions and volumes of diffusion restriction and perfusion deficit will be assessed on MR images. In a multivariable analysis, the investigators will find out whether Troponin elevations and ECG abnormalities are associated with infarct location or infarct size or both. In addition, the investigators will perform a voxel based analysis for correlation of infarct location and troponin elevations and ECG abnormalities.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Elevated Troponin and pathological EC | – | –Patients with acute ischemic stroke with elevated Troponin |
| No elevated Troponin or pathological EC | – | –Patients with acute ischemic stroke without elevated Troponin |
| Elevated Troponin, pathological ECG & coronary angiography | – | –Patients with acute ischemic stroke with elevated Troponin T and pathological ECG and coronary angiography |
| No elevated Troponin, pathological ECG & coronary angiography | – | –Patients with acute ischemic stroke without elevated Troponin T and pathological ECG and coronary angiography |
Who may qualify
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All patients with acute ischemic stroke hospitalized at Inselpital Berne between 2004-2014.
Key inclusion criteria (5 listed)
- Age ≥16 years
- Hospitalized between 2004-2014
- Acute MRI imaging performed
- ECG on admission
- Cardiac lab parameters on admission (TnT, CK, CK-MB)
Key exclusion criteria (3 listed)
- Age <16 years
- No acute MRI image
- No lab parameters
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Association of ischemic lesion size and impaired heart regulation at baseline
Time frame: At baseline
Association is to be determined via multivariate logistic regression. Baseline parameter at inclusion; functional outcome/mortality after 3 months.
Association of ischemic lesion size and impaired heart regulation after 3 months
Time frame: After 3 months
Association is to be determined via multivariate logistic regression. Baseline parameter at inclusion; functional outcome/mortality after 3 months.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Apr 2016.
- Background: PubMed 2353094Edelman RR, Mattle HP, Atkinson DJ, Hill T, Finn JP, Mayman C, Ronthal M, Hoogewoud HM, Kleefield J. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology. 1990 Jul;176(1):211-20. doi: 10.1148/radiology.176.1.2353094.
- Background: PubMed 1987608Mattle HP, Wentz KU, Edelman RR, Wallner B, Finn JP, Barnes P, Atkinson DJ, Kleefield J, Hoogewoud HM. Cerebral venography with MR. Radiology. 1991 Feb;178(2):453-8. doi: 10.1148/radiology.178.2.1987608.
- Background: PubMed 22363057Galimanis A, Jung S, Mono ML, Fischer U, Findling O, Weck A, Meier N, De Marchis GM, Brekenfeld C, El-Koussy M, Mattle HP, Arnold M, Schroth G, Gralla J. Endovascular therapy of 623 patients with anterior circulation stroke. Stroke. 2012 Apr;43(4):1052-7. doi: 10.1161/STROKEAHA.111.639112. Epub 2012 Feb 23.
- Background: PubMed 23471266Heldner MR, Zubler C, Mattle HP, Schroth G, Weck A, Mono ML, Gralla J, Jung S, El-Koussy M, Ludi R, Yan X, Arnold M, Ozdoba C, Mordasini P, Fischer U. National Institutes of Health stroke scale score and vessel occlusion in 2152 patients with acute ischemic stroke. Stroke. 2013 Apr;44(4):1153-7. doi: 10.1161/STROKEAHA.111.000604. Epub 2013 Mar 7.
- Background: PubMed 9366581Walpoth BH, Walpoth-Aslan BN, Mattle HP, Radanov BP, Schroth G, Schaeffler L, Fischer AP, von Segesser L, Althaus U. Outcome of survivors of accidental deep hypothermia and circulatory arrest treated with extracorporeal blood warming. N Engl J Med. 1997 Nov 20;337(21):1500-5. doi: 10.1056/NEJM199711203372103.
Related trials for Myocardial Infarction
RecruitingObservational study
Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation
Atrial Fibrillation (AF)
RecruitingObservational study
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
Heart Failure, Muscle Atrophy
Not yet recruitingPhase 3
Cilostazol for Prevention of Recurrent Stroke Trial
Stroke Recurrence, Myocardial Infarction
Recruiting
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Cardiogenic Shock, Acute Myocardial Infarction of Inferior Wall
Recruiting
Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)
Myocardial Infarction (MI)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Heinrich P Mattle, Prof. MD principal investigator
Dep. of Neurology, Bern University Hospital, Bern
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Myocardial Infarction and Stroke, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Association of ischemic lesion size and impaired heart regulation at baseline (time frame: At baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02734082, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2016.